Children with cancer have complete responses in a Children's Oncology Group phase 1 trial
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
May 17, 2012
0
0